Suppr超能文献

温血心脏停搏液

Warm blood cardioplegia.

作者信息

Vaughn C C, Opie J C, Florendo F T, Lowell P A, Austin J

机构信息

Phoenix Baptist Hospital, Phoenix, Arizona.

出版信息

Ann Thorac Surg. 1993 May;55(5):1227-32. doi: 10.1016/0003-4975(93)90039-k.

Abstract

Between 1990 and 1992, 346 consecutive patients underwent coronary artery bypass procedures. Ninety-eight patients (group A) from 1990 served as historical controls, and 248 patients (group B) from 1991 to 1992 served as a prospective, consecutive cohort for statistical comparison. The two groups varied in the type of myocardial protection used: intermittent cold crystalloid cardioplegia was used in group A and continuous warm blood cardioplegia in group B. (Two patients in group A received intermittent cold blood cardioplegia, and these 2 patients are grouped with the crystalloid group for the sake of convenience. The presence or absence of these 2 patients did not alter the group A statistics in any noticeable manner). Class IV high-risk groups demonstrated a 63% reduction in mortality (p = 0.07), and overall group B experienced a 28% reduction in mortality (4.4% versus 6.1%; p = not significant), an 86% reduction in perioperative myocardial infarction rate (1.6% versus 12.2%; p < 0.05), a 20% reduction in postoperative bleeding (275 versus 345 mL.day-1.m-2), and a marked reduction in reentry rates (p = 0.05). Also noted was a 32% reduction in postoperative ventilation requirements (25 versus 37 hours; p = 0.05). Less inotrope was required and intraoperative stroke was not seen in the patients with warm blood cardioplegia. Group B patients were less likely to have development of complex postoperative arrhythmias. Ventricular fibrillation at unclamping was noticeably rare (2.0% in group B versus 84% in group A; p < 0.05). The average group B heart resumed sinus rhythm 72 seconds after declamping.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1990年至1992年期间,346例连续患者接受了冠状动脉搭桥手术。1990年的98例患者(A组)作为历史对照,1991年至1992年的248例患者(B组)作为前瞻性连续队列用于统计比较。两组在心肌保护类型上有所不同:A组使用间歇性冷晶体心脏停搏液,B组使用持续温血心脏停搏液。(A组有2例患者接受间歇性冷血心脏停搏液,为方便起见,这2例患者与晶体液组归为一组。这2例患者的存在与否并未以任何显著方式改变A组的统计数据)。IV级高危组死亡率降低了63%(p = 0.07),总体上B组死亡率降低了28%(4.4%对6.1%;p无统计学意义),围手术期心肌梗死率降低了86%(1.6%对12.2%;p < 0.05),术后出血减少了20%(275对345 mL·天⁻¹·m⁻²),再入院率显著降低(p = 0.05)。还注意到术后通气需求降低了32%(25对37小时;p = 0.05)。温血心脏停搏液的患者所需的血管活性药物较少,术中未出现中风。B组患者术后发生复杂心律失常的可能性较小。开放主动脉时心室颤动明显少见(B组为2.0%,A组为84%;p < 0.05)。B组心脏平均在开放主动脉后72秒恢复窦性心律。(摘要截取自250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验